News

The NIH's Jay Bhattacharya tried his best pitch to explain the Trump administration's shift away from mRNA vaccine research.
RNA vaccines were a game-changer in the fight against COVID-19 — but now, their future could be shifting. The U.S. Department ...
RNA drugs might be able to protect against a huge range of viruses by turning on key parts of our innate defences against ...
So far, Secretary of Health and Human Services Robert F. Kennedy Jr., has done nothing about the pesticides in our foods, the ...
Elicio's mKRAS-targeting cancer vaccine reduced the risk of death by 77% by activating the anti-tumour mechanisms of key ...
Health Secretary Robert F. Kennedy Jr. has refused to acknowledge how his anti-vaccine rhetoric endangers public health ...
Public health workers and gun safety advocates gathered at a rally Tuesday night to commemorate last week’s deadly shooting near Emory University and the Centers for Disease Control and Prevention, ...
Ripple effect’: SNAP cuts to affect local healthy-living programs Educational extensions that are part of SNAP, the federal ...
( NewsNation) — National Institutes of Health director Jay Bhattacharya believes mRNA vaccine technology is “promising” but has failed at “earning public trust,” speaking one week after the federal ...